Evidence map›Paper›PMID 26632255›Full record

ArticleScientific reports2015

Acetaminophen cytotoxicity is ameliorated in a human liver organotypic co-culture model.

Leonard J Nelson, Maria Navarro, Philipp Treskes, Kay Samuel, Olga Tura-Ceide, Steven D Morley, Peter C Hayes, John N Plevris

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
7.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Novel emerging cell and organoid systems for the study of drug metabolism and toxicity in humans.Drug metabolism and disposition: the biological fate of chemicals · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Liver 'organ on a chip'.Experimental cell research · 2018
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Leonard J NelsonDepartment of Hepatology, Hepatology Laboratory, University of Edinburgh, Edinburgh, UK.
Maria NavarroDepartment of Hepatology, Hepatology Laboratory, University of Edinburgh, Edinburgh, UK.
Philipp TreskesDepartment of Hepatology, Hepatology Laboratory, University of Edinburgh, Edinburgh, UK.
Kay SamuelScottish National Blood Transfusion Service (SNBTS); Cell Therapy Research Group, Scottish Centre for Regenerative Medicine, University of Edinburgh, UK.
Olga Tura-CeideDepartment of Pulmonary Medicine, Hospital Clínic-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS); University of Barcelona. Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Spain.
Steven D MorleyDepartment of Hepatology, Hepatology Laboratory, University of Edinburgh, Edinburgh, UK.
Peter C HayesDepartment of Hepatology, Hepatology Laboratory, University of Edinburgh, Edinburgh, UK.
John N PlevrisDepartment of Hepatology, Hepatology Laboratory, University of Edinburgh, Edinburgh, UK.
University of Edinburgh · GBConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESScottish National Blood Transfusion Service · GB

Funding

Biotechnology and Biological Sciences Research Council BB/L023687/1Chief Scientist Office ETM/182
6 · The paper itself

Abstract

Organotypic liver culture models for hepatotoxicity studies that mimic in vivo hepatic functionality could help facilitate improved strategies for early safety risk assessment during drug development. Interspecies differences in drug sensitivity and mechanistic profiles, low predictive capacity, and limitations of conventional monocultures of human hepatocytes, with high attrition rates remain major challenges. Herein, we show stable, cell-type specific phenotype/cellular polarity with differentiated functionality in human hepatocyte-like C3A cells (enhanced CYP3A4 activity/albumin synthesis) when in co-culture with human vascular endothelial cells (HUVECs), thus demonstrating biocompatibility and relevance for evaluating drug metabolism and toxicity. In agreement with in vivo studies, acetaminophen (APAP) toxicity was most profound in HUVEC mono-cultures; whilst in C3A:HUVEC co-culture, cells were less susceptible to the toxic effects of APAP, including parameters of oxidative stress and ATP depletion, altered redox homeostasis, and impaired respiration. This resistance to APAP is also observed in a primary human hepatocyte (PHH) based co-culture model, suggesting bidirectional communication/stabilization between different cell types. This simple and easy-to-implement human co-culture model may represent a sustainable and physiologically-relevant alternative cell system to PHHs, complementary to animal testing, for initial hepatotoxicity screening or mechanistic studies of candidate compounds differentially targeting hepatocytes and endothelial cells.

Indexed as

AcetaminophenCell SurvivalCoculture TechniquesHumansHuman Umbilical Vein Endothelial CellsLactatesLiverMitochondriaPyruvic AcidToxicity TestsAcetaminophenLactatesPyruvic Acid

Identifiers

PMID26632255
PMCPMC4668374
OpenAlexW2186041147

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.